Acute promyelocytic leukemia: a paradigm for differentiation therapy.
about
Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cellsDe-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signalingThe Combination of Three Natural Compounds Effectively Prevented Lung Carcinogenesis by Optimal Wound HealingA calibrated agent-based computer model of stochastic cell dynamics in normal human colon crypts useful for in silico experiments.Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and TherapyRARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiationCharacterisation of genome-wide PLZF/RARA target genes.The PML domain of PML-RARα blocks senescence to promote leukemiaCD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.Retinoids and rexinoids in cancer prevention: from laboratory to clinic.Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.Gene expression profiling in MDS and AML: potential and future avenues.The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia.JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in CancerHOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cellsRetinoid differentiation therapy for common types of acute myeloid leukemia.CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiaMolecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.Pro-differentiating effects of a synthetic flavagline on human teratocarcinomal cancer stem-like cells.Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
P2860
Q28541829-D46C0A2E-BC68-44BD-8FC3-21B76CF008F1Q28542879-91FD73E1-0416-4A87-A4DD-DE42E71FC41EQ28551140-27EBB6E8-A8FE-4387-98A9-7364B7B1144DQ30561752-B204F670-0147-4232-927E-CFA2F39F2592Q31074800-DD221C14-2907-4092-A44D-30DAA005F277Q33991449-A603FDC9-5C44-427F-8B83-45B1D4E4085EQ34031285-515448AA-56CA-4F2F-ACBA-5EED280B8BECQ34082734-31BF861D-2C5B-4F99-A5A6-396ADE3AC061Q34629236-ED82ED82-2A86-436D-B843-AD4FB22AAA40Q35560264-4F154927-B371-49CA-B020-FE7A03258046Q35971837-DDBF374C-E9DC-4105-BE95-B429C748A1B3Q36301520-E0116CC4-5360-4D79-97D5-9FDD23A48B41Q36680198-D2A72451-A880-450A-B158-79AC4BCA9B2EQ37212864-F5EF0700-0827-44BF-BF8D-40E30577D770Q37858877-28B8F876-80F5-4B3C-9A9E-DDF9DA0F3D1EQ37952402-C32922B5-E193-4693-9FCD-6CEC2A11F7ECQ38688601-D238995C-A183-4303-8970-7E959B6FD51AQ38807596-86C8D4B7-35DF-4D2D-B1A4-D2F6FAB9C674Q38957651-79CFA32D-BC1A-4F13-B19D-3544CAA4BDD9Q41723841-C1CDFB7D-171D-4431-998C-75C1ED6F51C4Q42323497-9BFF445E-0D34-4920-B2F5-2C75966362A6Q49175540-135F88B6-8ED9-4C2B-859D-0DE4D93FE30EQ51258728-D058ADCC-1492-4025-A719-8D62A734752FQ52758028-BCC48148-8F81-4AD6-AB9E-6219B0021AFE
P2860
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@en
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@nl
type
label
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@en
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@nl
prefLabel
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@en
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@nl
P2093
P1476
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
@en
P2093
Anita R Mistry
David Grimwade
Ellen Solomon
P304
P356
10.1007/978-0-387-69259-3_13
P577
2010-01-01T00:00:00Z